Friday will see a flurry of biotech IPOs, part of what one observer cited in today’s article describes as “a rush to get deals before the election and while the market is strong.” For a look at the four biotech companies going public Friday – which include two firms developing small molecule therapies to treat cancer – CLICK HERE.
A Friday Flurry Of Biotech IPOs
- by Alex Clarke
